The IPO Buzz: AgomAb Therapeutics (AGMB) Prices IPO at $16 & Joins ‘The Mid-Point Club’

Mid-point pricing is the trend. AgomAb Therapeutics NV  (AGMB), a Belgian biotech backed by Pfizer, priced its IPO at $16.00 – the mid-point of its range – last night. That put AgomAb Therapeutics right in step with SpyGlass Pharma (SGP) and Jennifer Garner’s Once Upon a Farm (OFRM) – both IPOs also priced at the mid-point of their respective ranges last night – after a brutal..

Read more February 6, 2026

IPO Calendar

Company Symbol proposed Lead Managers Shares (Millions) Price Low Price High Est. $ Volume Expected to Trade SCOOP Rating Rating Change
Cambridge Acquisition CAQU BTIG 20.0 10.00 10.00 $ 200.0 mil 2/6/2026 Priced S/O S/O
Once Upon a Farm, PBC OFRM Goldman Sachs/J.P. Morgan/BofA Securities/William Blair/Barclays/Evercore ISI/Deutsche Bank Securities/Oppenheimer & Co./TD Cowen 11.0 18.00 18.00 $ 198.0 mil 2/6/2026 Priced S/O S/O
SPACSphere Acquisition Corp. SSAQU D. Boral Capital (ex-EF Hutton) 15.0 10.00 10.00 $ 150.0 mil 2/6/2026 Priced S/O S/O
Read more

Last 100 IPOs - February 7, 2026

Number of IPOs priced : 100
Number Up: 54
Number Down: 42
Number Unchanged: 4
Percentage Change From Issue Price: -2.78%
Percentage Change for The Nasdaq Composite 35.22%

2026 IPO Scorecard - February 7, 2026

Number of IPOs priced (Excluding 28 units) : 21
Number Up: 12
Number Down: 8
Number Unchanged: 1
Total Return From Issue Price: 7.03%
The Nasdaq Composite Index YTD % Change 35.22%